Company Leadership and Strategy - The Alkaline Water Company, Inc. has announced the return of co-founder Ricky Wright as President and CEO, aiming to lead the company into its next growth phase [1][2] - Wright's return aligns with the company's plan to file a Form 15c211 application with FINRA, which is essential for gaining eligibility for proprietary broker-dealer quotations and continuous market making [2] Market Position and Product Offering - The company aims to solidify its position in the alkaline water market, which is supported by a growing consumer focus on health and wellness [3] - Under previous leadership, Alkaline88® became the largest independent alkaline water company in the U.S., with a presence in over 75,000 stores nationwide [3] Mission and Vision - The company's mission is to provide consumers with clean, pure drinking water that enhances their overall wellness journey [4]

SCOTTSDALE, Ariz., Oct. 25, 2024 /PRNewswire/ -- The Alkaline Water Company, Inc. (OTC: WTER), a leader in the beverage industry known for its purified alkaline water, enhanced with Himalayan rock salt, will be filing its Form 211 application with FINRA with an appropriate market maker (who will make in initial review under SEC Rule 15c211) to become eligible for proprietary broker-dealer quotations, publish competing quotes, and more importantly, provide continuous market making.At the current time, the Co ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-38754 THE ALKALINE WATER COMPANY INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Nevada 99-036704 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: March 31, 2023 or [] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to __________________ Commission file number: 001-38754 THE ALKALINE WATER COMPANY INC. (Exact name of registrant as specified in its charter) ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38754 THE ALKALINE WATER COMPANY INC. (480) 656-2423 (Registrant's telephone number, including area code) Not Applicable (Former name, former address and former fiscal y ...

The Alkaline Water Company Inc. (OTC:WTER) Q2 2023 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants Jeff Wright - Investor Relations Frank Lazaran - President and Chief Executive Officer David Guarino - Chief Financial Officer Operator Greetings. Welcome to the Alkaline Water Company Second Quarter Fiscal Year 2023 Conference Call. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to your host, Jeff Wright. You may begin. Jef ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-38754 THE ALKALINE WATER COMPANY INC. (Exact name of registrant as specified in its charter) | Title of Each Class | Trading Symbol(s) | Name of each exchange on which ...

```markdown [PART I - FINANCIAL INFORMATION](index=3&type=section&id=PART%20I%20-%20FINANCIAL%20INFORMATION) This section details the unaudited financial statements and management's analysis of the company's financial performance [Item 1. Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) The company's unaudited financial statements show revenue growth, declining gross profit, a net loss, and a going concern warning [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Total assets and liabilities increased, resulting in a working capital deficit and a slight rise in stockholders' equity Balance Sheet Highlights | Balance Sheet Highlights | June 30, 2022 | March 31, 2022 | | :--- | :--- | :--- | | **Assets** | | | | Cash | $2,945,924 | $1,531,062 | | Inventory | $10,678,339 | $8,583,664 | | Total Current Assets | $26,597,195 | $21,157,421 | | Total Assets | $28,561,030 | $22,500,577 | | **Liabilities & Equity** | | | | Accounts Payable | $11,934,494 | $10,441,879 | | Accrued Expenses | $5,946,778 | $2,036,739 | | Total Current Liabilities | $27,828,934 | $21,920,686 | | Total Liabilities | $27,935,661 | $22,099,439 | | Total Stockholders' Equity | $625,369 | $401,138 | [Condensed Consolidated Statement of Operations](index=5&type=section&id=Condensed%20Consolidated%20Statement%20of%20Operations) Net revenue increased, but gross profit declined significantly due to rising costs, leading to a stable net loss Income Statement (Three Months Ended) | Income Statement (Three Months Ended) | June 30, 2022 | June 30, 2021 | Change (YoY) | | :--- | :--- | :--- | :--- | | Net Revenue | $16,894,403 | $14,113,578 | +19.7% | | Cost of Goods Sold | $13,399,774 | $9,311,011 | +43.9% | | Gross Profit | $3,494,629 | $4,802,567 | -27.2% | | *Gross Margin* | *20.7%* | *34.0%* | *-13.3 pts* | | Total Operating Expenses | $9,785,839 | $12,120,774 | -19.3% | | Operating Loss | ($6,291,210) | ($7,318,207) | +14.0% | | Net Loss | ($7,493,408) | ($7,425,626) | -0.9% | | Loss Per Share (Basic and Diluted) | ($0.06) | ($0.08) | +25.0% | [Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash used in operations decreased, while financing activities provided substantial cash, leading to a net cash increase Cash Flow (Three Months Ended) | Cash Flow (Three Months Ended) | June 30, 2022 | June 30, 2021 | | :--- | :--- | :--- | | Net Cash Used in Operating Activities | ($2,494,650) | ($6,055,313) | | Net Cash Used in Investing Activities | ($854,997) | ($61,444) | | Net Cash Provided by Financing Activities | $4,764,509 | $1,483,706 | | **Net Change in Cash** | **$1,414,862** | **($4,633,051)** | | Cash at End of Period | $2,945,924 | $4,497,905 | [Notes to Condensed Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Notes detail business, accounting policies, customer concentration, going concern, and subsequent debt settlement events - The company's products include **bottled alkaline water** and **hemp-derived CBD bottled water**[17](index=17&type=chunk) - There is significant customer concentration risk, with two customers representing **31% of total revenue** for the quarter ended June 30, 2022[30](index=30&type=chunk) - The company has accumulated net losses of **$117 million** since inception, raising **substantial doubt about its ability to continue as a going concern**. Management plans to raise additional funds through offerings to support operations[38](index=38&type=chunk)[39](index=39&type=chunk) - Subsequent to the quarter end, on July 25, 2022, the company settled debt of **$3.87 million** by issuing units (stock and warrants). The immediate exercise of these warrants was expected to bring in approximately **$4.24 million** in cash[69](index=69&type=chunk)[70](index=70&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=19&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses revenue growth, gross margin decline due to inflation, and strategies to address going concern risks [Results of Operations](index=20&type=section&id=Results%20of%20Operations) Revenue grew due to expanded distribution, but cost of goods sold increased significantly, impacting gross margin - Revenue increased by **20% YoY** due to expanded distribution of products to additional retailers across the country, including major national distributors and direct retail clients like Walmart, CVS, and Kroger[82](index=82&type=chunk) - Cost of goods sold as a percentage of revenue increased from **66%** to **79% YoY**, driven by increased raw material and freight costs[83](index=83&type=chunk) - The company has implemented an approximate **9% price increase** and is taking other steps to improve margins, such as optimizing freight costs and locking in prices on raw materials[80](index=80&type=chunk) [Liquidity and Capital Resources](index=21&type=section&id=Liquidity%20and%20Capital%20Resources) The company faces a working capital deficit and relies on financing, implementing cost-reduction and margin-enhancement plans Working Capital | Working Capital | June 30, 2022 | March 31, 2022 | | :--- | :--- | :--- | | Current Assets | $26,597,195 | $21,157,421 | | Current Liabilities | $27,828,934 | $21,920,686 | | **Working Capital (Deficit)** | **($1,231,739)** | **($763,265)** | - The increase in accrued liabilities is primarily due to receiving approximately **$3 million** in proceeds for warrants exercised as part of a debt settlement that closed after the quarter-end (on July 25, 2022)[89](index=89&type=chunk)[95](index=95&type=chunk) - The company has begun implementing **cost-reduction measures** (restructuring, reduced professional/marketing spend) and **margin enhancements** (packaging changes, pricing optimization) to fund operations[97](index=97&type=chunk) [Item 4. Controls and Procedures](index=23&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were ineffective due to previously disclosed material weaknesses - Management, including the CEO and CFO, concluded that the company's disclosure controls and procedures were **not effective** as of the end of the quarter[102](index=102&type=chunk) - The ineffectiveness was attributed to **material weaknesses in internal control over financial reporting** previously disclosed in the Form 10-K for the fiscal year ended March 31, 2022[102](index=102&type=chunk) [PART II - OTHER INFORMATION](index=24&type=section&id=PART%20II%20-%20OTHER%20INFORMATION) This section covers legal proceedings, risk factors, equity sales, and a list of exhibits [Item 1. Legal Proceedings](index=24&type=section&id=Item%201.%20Legal%20Proceedings) The company is not a party to any material pending legal proceedings, nor is it aware of any contemplated by authorities - The company is **not aware of any material pending legal proceedings** to which it or its subsidiaries are a party[105](index=105&type=chunk) [Item 1A. Risk Factors](index=24&type=section&id=Item%201A.%20Risk%20Factors) No material changes have occurred to the risk factors previously disclosed in the company's most recent annual report - **No material changes have occurred** since July 14, 2022, from the risk factors disclosed in the company's most recent Form 10-K[107](index=107&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=24&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company granted its CEO restricted shares and stock options as unregistered securities after the quarter-end - On July 29, 2022, the company granted its CEO, Frank Lazaran, an award of **500,000 restricted shares** and options to purchase **1,000,000 shares** of common stock[109](index=109&type=chunk) - The stock options have an exercise price of **$0.428 per share**, a ten-year term, and vest in two equal 50% installments on the first and second anniversaries of the grant date[109](index=109&type=chunk) [Item 6. Exhibits](index=25&type=section&id=Item%206.%20Exhibits) This section lists all exhibits filed, including a new employment agreement and required officer certifications - A **new employment agreement** with Frank Lazaran, dated July 29, 2022, was filed as an exhibit[116](index=116&type=chunk) - The list includes **various historical articles of incorporation, material contracts, and underwriting agreements**, many of which are incorporated by reference from previous filings[113](index=113&type=chunk)[114](index=114&type=chunk)[115](index=115&type=chunk) ```

THE A CORPORATE PRESENTATION JUNE 2022 NASDAQ & CSE: WTER Cautionary Note Regarding Forward-Looking Statement and Health Claims 2 Cautionary Note Regarding Forward-Looking Statement and Health Claims This presentation contains forward-looking statements relating The Alkaline Water Company Inc. (the "Company"). Statements in this presentation that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such ...

Alkaline Water Company Inc. (OTC:WTER) Q4 2022 Earnings Conference Call July 15, 2022 8:45 AM ET Company Participants Jeff Wright - Director of Investor Relations Frank Lazaran - President & Chief Executive Officer David Guarino - Chief Financial Officer Frank Chessman - Executive Director of Sales & Operations Conference Call Participants Kevin Dede - H.C. Wainwright Operator Greetings. Welcome to the Alkaline Water Company's Full Year Fiscal 2022 Earnings Call. At this time, all participants are in a list ...